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~ Magnetic Resonance Angiography Versus 
Conventional X-Ray Anglography of  Anomalous 
Coronary Arteries 
Johances C. Post, Albert C. van Rossum, Jean G.F. Bronzwaer, Carel C. de 
Cock, Mark B.M. Herman, Jacob Vail',, Coes A. Vfaser. Free University 
Hospital, Amsterdam, Netherlands; ICIN, Utrecht, Netherlands 
Background'. The sequelae of anomalously odginsting coronary artedss 
(CAst depend on their course with respect o the great arteries. Delineation of 
this course from conventional X-rey coronary angiograms (X-CAG) is some- 
times equivocal, purpose:To investigate the accuracy of magnetic resonance 
coronary angiography (MRCA) in (I) differentiating anomalous from normal 
coronary anatomy; (2) determining the odgin, and (3) delineating the proxi- 
mal course of anomalous CAs. Methods: 38 pts with previous X-CAG (19 CA 
anomalies; 19 normal) were investigated using fast two-dimensional MRCA 
during breath-holds. A standard imaging protocol of transverse and oblique 
images was used. Cine-lcops of consecutive images were recorded in ran- 
dom order on videotape for analysis by 2 independent observers blinded to 
the results of X-CAG. All X-CAGs were reviewed by 2 cath-taD cardiologists 
blinded to MRCA results. Results: Using MRCA 18 pts were diagnosed to 
have normal and 19 pts to have anomalous CA anatomy: 4 LMCA from dght 
aortic sinus JR] (1 interartedal, 2 retro-aortic, 1 antedor free wall course); 1 
LAD from R (septet); 11 LCx from R (11 retm-aorfio); and 4 RCA from left 
aortic sinus (4 interartedal). In I pt the LAD and LCx both arose anomalously. 
I pt could not hold her breath and was excluded. Intorobserver vadabifity was 
zero. Agreement with X-CAG was 100°/, for differentiating anomalous from 
normal anatomy and for determining the CA origin. In 3 cases inconsistency 
in diagnosis of the proximal course existed between MRCA and X-CAG. 
Consensus after joint review of these cases was that MRCA diagnosis was 
unambiguous and X-CAG diagnosis erroneous. 
Conclusions: MRCA is highly accurate in differentiating anomalous from 
normal CA anatomY, in determining the anomalous odgin and in delineating 
the clinically important proximal course. The technique may be considered 
as a new clinical standard for this purpose. 
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Successful Gene Therapy Fol lowing Direct Injection 
o f  Naked DNA Encoding Secreted Protein Into 
Skeletal Muscle 
Yukio Tsurumi, Satoshi Takeshita, Jonathan Passed, Marianne Keamay, 
Jeffrey R. Horowilz, James 1=. Symas, Jeffrey M. Isner. St. Elizabeth's 
Medical Center, Tufts University School of Medicine, Boston, MA 
Although transfectibn of skeletal muscle with naked DNA has been performed 
previously, the levels of gene expression have been judged to be insufficient 
to achieve a therapeutic outcome. Work in our laboratory, however, has 
indicated that for the gene encoding secreted proteins, a therapeutic ef- 
fect may be achieved, despite a low transfection efficiency. Accordingly, this 
study was conducted to investigate therapeutic potential of intramuscular 
(IM) gene therapy for hindllmb ischemla using the naked DNA encoding 
vascular endothelial growth factor (VEGF), which is an endothelial specific 
mitngan containing signal sequences. Ischemia was induced in one hindlimb 
of rabbits by excision of a femoral artery. After 10 days of recovery, we di- 
rectty injected 500/zg of phVEGF lss into the ischemic hindlimb muscles. 
Animals transfected with tM LacZ gene were used as controls. At day 30 
after treati~ant` VEGF transfected animals had more angiogrephicalty rec- 
egn|zabte collatsrat vessels (angingraph|c score = 0.80 ± 0.1 versus 0.53 
+ 0.1, p < 0.01) and histolOgically assessed capillaries (278 =1:36 versus 
192 -4- 29/mm2, p < 0.01), compared to control. Hemodynamic deficit was 
less severe in VEGF transtscted animals by calf systolic blood pressure ratio 
(0.85 4- 0.1 versus 0.62 ± 0.1, p < 0.01) and by flow to the ischemic limb 
measured with Doppler guidewire (baseline flow = 19.4- 5 versus 14:1:5 
ml/min, p < 0.01; hyperemic flow = 53 -i- 5 versus 37 -4-12 ml/min, p < 0.01). 
Pertusion to tschemlc muscles, assessed by colored mlcrospheres, was 1.5 
fold greater in VEGF transfected animals (p < 0.05). RT-PCR disclosed hu- 
man VEGF mRNA expressed in ischemic muscle as long as 14 days after 
injection. Conclusions: Gene therapy with IM transfer of naked VEGF plasmid 
represents a feasible, simpler alteroativo strategy to catheter-based intrevas- 
cular delivery for therapeutic anglogenests in patients with lower extremity 
vascular insufficiency. 
Methodology- New and Not  So  New 
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~"~ Potential Value of  Antagonist  Platelet GPIIb/llla for 
Treating Heparin-lnduced Thrombocytopenla (HIT) 
Koon-Hou Mak, Kandice Koftke-Marohant, Linda M. Brooks, Kdstopher 
L. Apheart, Eric J. Topoi. The Cleveland Clinic Foundation, Cleveland, OH 
Introduction HiT is a common adverse effect of heparin therapy that carries 
a risk of serious thrombotic events. This condition is caused by platelst 
aggregation, which is mediated by anti-heparin/platolet factor 4 antibodies; 
There is no specific treatment for this disorder, especially once thrombosis 
occurs. Therefore, we evaluate the in-vitro efficacy of a GPllb/llla receptor 
antagonist in this disorder. Methods: Inhibition of hepadn-inducad platclst 
aggregation of aboxlmab was tested in platelet-poor plasma (from 23 patients 
with HIT), platelet.dch plasma (from b~xI group "O" donors with known 
reactivity), heparin (0.5 U/ml), and ascending doses of eboximab (0.0703, 
0.1406, 0.2812 and 0.5625 /zg/ml). Aboximab inhibition of ADP-induced 
aggregation served as a control. Results:Abcximab (g/zg/ml) inhibited 87.2% 
(SO ± 3.4) of ADP-induced platelet aggregation. A dose-dependant inhibition 
of heparin-inducad platslet aggregation was observed. 
%id~lddm of b~i ,d ,e¢ l  
Io 
Conclusion: Abcximab is efficacious in inhibiting in.Wire heparin-induced 
platslst aggregation in plasma from patients with HIT and warrants further 
clinical investigation. 
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( 800-31 Epidermal Growth Factor Receptor Expression and 
Its Relation to Smooth Muscle Cell Differentiation 
and Apoptssis in Human Carotid Plaques 
Sven Schtuckebler, Winfried Sigg, Ulrich Welsch, Reinhard Kandotf, 
Gerhard Baudedel. Dept. Int. Mad. I, Univ. of Munich, Inst. Pathol., Univ. Of 
TObingen, FRG 
Vascular growth factors and their receptors are considered to be involved 
in plaque formation. We sought to assess the conditions in which epidermal 
growth factor receptor (EGF-R) is expressed, using immunohistochemisfry, 
transmission electren microscopy (TEM) and m0rphometric analysis of hu- 
man carotid artery lesions. Our data reveal a mean of intimal cell density of 
877:1:324 coils/ram ~ (x 4- SD; n = 20 lesions). The 13 densest lesions ex- 
pressed EGF-R (Sigma); these had a threshold cellutadty of > 600 colls/m~ 
(correlation of EGF-R to intimal cell density = 0.78; p < 0.00i). No EGF-R 
was detected in medial regions. TEM analysis (Phiflps CM10) showed cell- 
rich intimal areas comprised of smooth muscle cells (SMCs), which exhibited 
numerous cytoplasmic organellas. Signalling partial SMC de-differentiation, 
the morphometric volume fraction of organalles/cytoplasm amounted to 0A5 
± 0.16 (n = 20). Again, this parameter correlated significantly with inUmal 
cell density (r = 0.7; p < 0.001), but not with EGF-R expression (r = 0.18; 
p = 0.41). In 8 lesions, c~trally located necrotic regicns were clearly de- 
marcated from cell-rich intima by a distinct cluster of macrophages (CD68; 
Dakopatts). In 5 lesions, an additional ayer of CD68-positive infiltrates was 
observed that spanned the central macrophege border and luminal plaque 
margins, indicating sites of plaque rapture. Apoptotio bodies (ABs), reflecting 
charactedstio features of programmed cell death, were found parUculady in 
these regions. ABs were located in the pericellular territories as wall as in the 
cytoplasm of nearby macrophages and SMCs, indicating their phagocytosis. 
Interestingly, the intimal density of ABs correlated inversely with cellularity 
(r = -0.54; p < 0.01), the degree of SMC de-differentiation (r= -0.43; p < 
0.05) and with EGF.R expression (r = -0.41; p = 0.05). 
In summary, our data demonstrate the expression of EGF-R in tuminalty 
located SMCs, but not in those from central or macrophage-rich areas. The 
relationship of EGF-R with cellularity, SMC de-differentiation and the number 
of apoptotic bodies indicates EGF-R to be a pathogenic factor in human 
plaque formation and pmgressibn, and in addition, suggests that EGF-R 
contributes in counterbalancing apoptotic events. 
